anmelden
FTSE All-Share
5.539,85
PKT
+30,20
PKT
+0,55
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu FTSE All-Share-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 08.06.16 | Shell (ex Royal Dutch Shell) overweight | Morgan Stanley | |
| 07.06.16 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
| 07.06.16 | Barclays buy | UBS AG | |
| 06.06.16 | Sky Equal-Weight | Morgan Stanley | |
| 06.06.16 | Diageo overweight | Morgan Stanley | |
| 06.06.16 | Shell (ex Royal Dutch Shell) buy | Société Générale Group S.A. (SG) | |
| 03.06.16 | BT Group neutral | Morgan Stanley | |
| 03.06.16 | Diageo overweight | JP Morgan Chase & Co. | |
| 03.06.16 | GSK buy | Goldman Sachs Group Inc. | |
| 03.06.16 | Imperial Brands buy | Goldman Sachs Group Inc. | |
| 02.06.16 | BT Group Sell | Deutsche Bank AG | |
| 01.06.16 | Prudential Conviction Buy List | Goldman Sachs Group Inc. | |
| 01.06.16 | Lloyds Banking Group Neutral | Goldman Sachs Group Inc. | |
| 01.06.16 | HSBC Neutral | Goldman Sachs Group Inc. | |
| 01.06.16 | Barclays Conviction Buy List | Goldman Sachs Group Inc. | |
| 01.06.16 | Prudential Hold | Société Générale Group S.A. (SG) | |
| 31.05.16 | GSK Equal-Weight | Morgan Stanley | |
| 31.05.16 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 31.05.16 | GSK Neutral | UBS AG | |
| 31.05.16 | Shell (ex Royal Dutch Shell) buy | UBS AG | |
| 27.05.16 | Vodafone Group Neutral | Goldman Sachs Group Inc. | |
| 26.05.16 | Shell (ex Royal Dutch Shell) buy | Deutsche Bank AG | |
| 26.05.16 | Barclays Outperform | BNP PARIBAS | |
| 25.05.16 | Vodafone Group buy | Deutsche Bank AG | |
| 25.05.16 | Rio Tinto overweight | Barclays Capital | |
| 24.05.16 | HSBC Hold | Deutsche Bank AG | |
| 24.05.16 | Lloyds Banking Group buy | Deutsche Bank AG | |
| 24.05.16 | Barclays Hold | Deutsche Bank AG | |
| 24.05.16 | BT Group Underperform | Macquarie Research | |
| 24.05.16 | Shell (ex Royal Dutch Shell) Neutral | JP Morgan Chase & Co. | |
| 24.05.16 | BP kaufen | JP Morgan Chase & Co. | |
| 24.05.16 | Imperial Brands overweight | Barclays Capital | |
| 23.05.16 | Vodafone Group market-perform | Bernstein Research | |
| 23.05.16 | BT Group Outperform | Bernstein Research | |
| 23.05.16 | Vodafone Group buy | UBS AG | |
| 20.05.16 | Diageo overweight | JP Morgan Chase & Co. | |
| 20.05.16 | National Grid Underperform | BNP PARIBAS | |
| 19.05.16 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
| 19.05.16 | Barclays overweight | JP Morgan Chase & Co. | |
| 19.05.16 | BT Group Conviction Buy | Goldman Sachs Group Inc. |